People Taking Glitazone Drugs For Diabetes Appear To Be Less Likely To Develop Parkinson’s.

reports that for the study, investigators “compared the medical records” of some 44,600 diabetes patients taking glitazones “against the records of more than 120,000 diabetes patients who did not take a glitazone.” Next, the researchers “tracked these records from 1999 – when glitazones were introduced to treat diabetes – until 2013.” The study authors found that “during that time, patients who used glitazones were 28 percent less likely to be diagnosed with Parkinson’s disease than those who never took one of the meds.http://www.reuters.com/article/2015/07/21/health-parkinsons-idUSL5N1011WJ20150721